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The cerebral glucose transporter SLC45A1 is mutated in individuals
with non-syndromic intellectual disability and epilepsy. M. Srour1,2, N.
Shimokawa3, F.F. Hamdan1, S. Dobrzeniecka4, G.A. Rouleau5, C. Poulin2,
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1C5, Canada; 2) Division of Pediatric Neurology, Montreal Children's Hospi-
tal-McGill University Health Center, Montreal, H3H 1P3, Canada; 3) Depart-
ment of Integrative Physiology, Gunma University Graduate School of Medi-
cine, Gunma 371-8511, Japan; 4) CHUM Notre-Dame Hospital Research
Center, Montreal, H2L 2W5, Canada; 5) Montreal Neurological Institute,
McGill University, Montreal, H3A 2B4, Canada.
We have identified a consanguineous Lebanese family with two sisters
affected with moderate non-syndromic intellectual disability and epilepsy of
unknown etiology. SNP genotyping was performed in the two affected sisters
as well as in their unaffected sibling. We identified 7 regions larger than
1Mb that were homozygous in the two affecteds but not in the unaffected
sister. Whole exome sequencing was performed in one affected individual.
The exome dataset was analyzed by looking for homozygous rare (<0.5%
minor allele frequency) coding and splicing variants found in the candidate
homozygous regions. We excluded variants that did not segregate with the
phenotype in the family or that were found in 95 ethnically-matched controls.
Of the remaining variants, only one missense variant in SLC45A1 (c.C629T/
p.A210V) was predicted damaging by Polyphen-2 and mutation taster.
SLC45A1 encodes a glucose transporter that has only recently been charac-
terized. Slc45a1 is highly expressed in the brain of mice, is induced after
hypercapnia and mediates glucose uptake along the pH gradient. We show
that Slc45a1-transfected COS-7 cells carrying the same c.C629T (p.A210V)
mutation exhibited a 40-50% decrease in intracellular glucose uptake, sug-
gesting that the mutation affects the function of the Slc45a1 transporter.
Mutations in another cerebral glucose transporter, GLUT1, are implicated
in neurologic disease and are well known to result in epilepsy with variable
degrees of intellectual disability, or movement disorders. Our results suggest
the possibility of specific treatment in the form of a ketogenic diet for the
family, and implicate for the first time SLC45A1 in human disease. Identifica-
tion of additional similarly affected families will be necessary to establish
SLC45A1 as a neurodevelopmental disease gene. Collaborations towards
this effort are welcome.
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Adducin function is essential for sustained changes in neuronal activ-
ity upon learning.V. Vukojevic1,2, F. Peter1,2, P. Demougin1,2, N. Hadziseli-
movic1,2, J.-F de Quervain2,3,4, A. Papassotiropoulos1,3,4, A. Stetak1,3,4.
1) University of Basel, Department of Psychology, Division of Molecular
Neuroscience, Birmannsgasse 8, 4055 Basel, Switzerland; 2) University of
Basel, Department Biozentrum, Life Sciences Training Facility, Klingelberg-
strasse 50/70, 4056 Basel, Switzerland; 3) University of Basel, Department
of Psychology, Division of Cognitive Neuroscience, Birmannsgasse 8, 4055
Basel, Switzerland; 4) University of Basel, University Psychiatric Clinics,
Wilhelm Klein-Strasse 27, 4055 Basel, Switzerland.
Identifying molecular mechanisms that underlie learning and memory is
one of the major challenges in neuroscience. Previously, we have reported
that genetic variability of the human ADD1 gene is significantly associated
with episodic memory performance in healthy young subjects. Taken the
advantages of the nematode Caenorhabditis elegans, we have shown that
α-adducin is required for consolidation of synaptic plasticity, for sustained
synaptic increase of AMPA-type glutamate receptor (GLR-1) content and
altered GLR-1 turnover dynamics. ADD-1, in a splice- form- and tissue-
specific manner, controlled the storage of memories presumably through
actin-capping activity (Vukojevic et al, 2012). In the present work, we further
investigated the effects of adducin dependent changes on neuronal activity
during synaptic transmission. With the help of genetically encoded calcium
indicators (GECIs) we visualized the neuronal activity in vivo in defined
neuronal populations. Specifically, we monitored calcium currents in neurons
crucial for avoidance behavior, especially in AVA and RIM neurons that
controll activation and inhibition of reversals. Taken together, the method
implemented enabled us to get the insight of function and integration at the
level of a single neuron. Moreover, we were able to caught in vivo, a single
neuronal cell in learning and memory formation. Remarkably, in add(lf)
mutants the learning phase induced changes in AVA and RIM neuronal
activity fail to be consolidated after 30 minutes. Therefore we were also
capable to investigate in vivo the role of neurons in memory storage. These
findings further support the role of ADD-1 in the stabilization of synapses,
changes in GLR-1 dynamics and finally modulations of neuronal activity
patterns. All together, our results suggest that the lack of adducin in AVA
interneuron has consequences on synapse remodelling and changes of
neuronal activity that are functionally reflected also in other members of the
motor network.
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Influence of Alzheimer's disease genes on cognitive decline: theGuan-
gzhou Biobank Cohort Study. S.S. Cherny1, H.S. Gui1, L. Xu2, P.C.
Sham1, C.Q. Jiang3, T.H. Lam2, B. Liu3, Y.L. Jin3, T. Zhu3, W.S. Zhang3,
G.N. Thomas4, K.K. Cheng4. 1) Psychiatry & Centre for Genomic Sciences,
Univ Hong Kong, Pokfulam, Hong Kong; 2) Department of Community Medi-
cine, School of Public Health, University of Hong Kong, Hong Kong; 3)
Guangzhou No. 12 Hospital, Guangzhou, China; 4) Public Health, Epidemiol-
ogy, and Biostatistics, University of Birmingham, Birmingham, UK.
Mild cogntive impairment is a reliable predictor of the future onset of clinical
dementia. In Hong Kong, the prevalences of very mild dementia and mild
dementia in people aged 70 years and older were estimated to be 8.5%
and 8.9%, respectively, in a population-based sample. For those subjects
with a clinical diagnosis of dementia, Alzheimer's disease (AD) was the
most common likely cause (73.5%), with 22.4% having vascular dementia
(VaD), and 3.9% dementia with symptoms of Parkinson’s disease. In addition
to the impact on the patient and their family members, the economic cost
of AD has been estimated to range from around $48,000 to $585,000 per
patient per year around the world. To identify risk factors involved in cognitive
decline, we selected 1325 extreme cognitive decline subjects and 1083
matched controls from Guangzhou Biobank Cohort Study (GBCS) for DNA
genotyping at 30 known AD associated SNPs. Full information maximum
likelihood (FIML) regression was adopted to analyse quantitative cognitive
change scores, while multiple logistic regression was used to investigate
the genetic effect of those variants on dichotomous phenotype. No allelic
association was found by individual variant analysis. At the level of genotypic
association, not only did we confirm that the APOE ε4 homozygote can
significantly predict cognitive decline (p < 0.05), but also revealed carriers
of the ACE rs1800764_C allele are more likely suffer decline than non-
carriers, especially in the samples without college education. However, these
effects together only explain 1.3% of the phenotypic variance, and suggest
that AD risk variants/genes are only minor predictors of cognitive decline
in these Chinese samples.
1191T
FineMapping andAssociation Analysis of Candidate Genes for Autism
Spectrum Disorder and Language Impairment in the NJLAGS Sample.
A. Hare1, A. Seto1, J. Flax1, M. Azaro1, S. Buyske2, C. Bartlett3, L. Brzustow-
icz1. 1) Department of Genetics, Rutgers University, Piscataway, NJ; 2)
Department of Statistics, Rutgers University, Piscataway, NJ; 3) Battelle
Center for Mathematical Medicine, The Research Institute at Nationwide
Children’s Hospital and The Ohio State University, Columbus, OH.
Over the past decade, the New Jersey Language and Autism Study
(NJLAGS) has collected families that contain one individual with autism and
another individual with Specific Language Impairment (SLI) but not autism.
This is the first study of its kind to investigate the share genetics between
autism and SLI. Using a comprehensive neuropsychological testing battery,
three categorical phenotypes: language impairment (LI), reading impairment
(RI), and social impairment (SRS-DT), and two quantitative phenotypes:
social impairment (SRS-QT) and obsessive-compulsive behaviors (YBOCS)
were developed. Autism proband scores were included in the quantitative
phenotypes and all categorical phenotypes included autism diagnosis as
impaired for language, reading, or social skills, respectively. A previous
study identified linkage in these families to 13q21.2 (YBOCS), 14q32.31
(SRS-QT), 15q25.1 (LI), 15q26.2 (SRS-DT), and 16p12.3 (RI). As genome-
wide association did not reveal strong evidence for association, Ingenuity
Pathway Analysis (IPA) was used to select candidate genes for fine mapping
analysis. Four groups were analyzed in IPA: communication impairment (LI
+ RI), social impairment (SRS-DT + SRS-QT), restricted/repetitive behaviors
(YBOCS), and an overall autism model (LI + RI + SRS-DT + SRS-QT +
YBOCS). Genes in each analysis group were given a score that corre-
sponded to the number of relevant functions identified by IPA. Seven of the
highest-ranking genes were selected for association analysis from the LI,
RI, and SRS-DT linkage regions: AKT1, JAG2, PTPN9A, SEMA7A, NTRK3,
FES, and SCCN1B. Each gene was fine mapped using an oligonucleotide
ligation assay and was analyzed for association using the KELVIN frame-
work. Each gene was analyzed for association to its respective phenotype
with and without the inclusion of autism diagnosis and for autism diagnosis
only. JAG2 yielded the strongest evidence for association (PPLD|L = 5%)
when autism diagnosis was included. When autism diagnosis was excluded,
NTRK3 yielded the strongest evidence for association (PPLD|L =7%). For
autism diagnosis only, no evidence for association was detected. The lack
of strong evidence for association provides support for a role of rare variants
in autism susceptibility and their role in the shared genetics between autism
and SLI.
